Healthequity annual gross margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Healthequity's gross margin was 69.52% for fiscal 2026.
View full Healthequity company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-01-31 | 69.52% | +4.74 pp |
| 2025 | 2025-01-31 | 64.78% | +2.49 pp |
| 2024 | 2024-01-31 | 62.29% | +5.20 pp |
| 2023 | 2023-01-31 | 57.09% | +0.94 pp |
| 2022 | 2022-01-31 | 56.14% | −0.47 pp |
| 2021 | 2021-01-31 | 56.62% | −4.64 pp |
| 2020 | 2020-01-31 | 61.26% | −1.82 pp |
| 2019 | 2019-01-31 | 63.08% | +4.30 pp |
| 2018 | 2018-01-31 | 58.78% | −0.85 pp |
| 2017 | 2017-01-31 | 59.63% | +2.37 pp |
| 2016 | 2016-01-31 | 57.26% | +2.66 pp |
| 2015 | 2015-01-31 | 54.60% | +1.71 pp |
| 2014 | 2014-01-31 | 52.89% | +0.56 pp |
| 2013 | 2013-01-31 | 52.33% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-04-30 | 72.27% | +4.47 pp |
| Q4 2026 | 2026-01-31 | 68.19% | +7.56 pp |
| Q3 2026 | 2025-10-31 | 70.79% | +5.21 pp |
| Q2 2026 | 2025-07-31 | 71.38% | +3.35 pp |
| Q1 2026 | 2025-04-30 | 67.80% | +2.73 pp |
| Q4 2025 | 2025-01-31 | 60.63% | −1.62 pp |
| Q3 2025 | 2024-10-31 | 65.58% | +1.71 pp |
| Q2 2025 | 2024-07-31 | 68.03% | +5.76 pp |
| Q1 2025 | 2024-04-30 | 65.07% | +4.33 pp |
| Q4 2024 | 2024-01-31 | 62.24% | +4.05 pp |
| Q3 2024 | 2023-10-31 | 63.87% | +5.17 pp |
| Q2 2024 | 2023-07-31 | 62.27% | +5.12 pp |
| Q1 2024 | 2023-04-30 | 60.74% | +6.69 pp |
| Q4 2023 | 2023-01-31 | 58.20% | +5.88 pp |
| Q3 2023 | 2022-10-31 | 58.71% | +1.29 pp |
| Q2 2023 | 2022-07-31 | 57.15% | −2.06 pp |
| Q1 2023 | 2022-04-30 | 54.05% | −1.93 pp |
| Q4 2022 | 2022-01-31 | 52.32% | −1.32 pp |
| Q3 2022 | 2021-10-31 | 57.41% | −0.88 pp |
| Q2 2022 | 2021-07-31 | 59.21% | +1.39 pp |
| Q1 2022 | 2021-04-30 | 55.98% | −0.90 pp |
| Q4 2021 | 2021-01-31 | 53.63% | −2.87 pp |
| Q3 2021 | 2020-10-31 | 58.30% | −2.82 pp |
| Q2 2021 | 2020-07-31 | 57.82% | −9.65 pp |
| Q1 2021 | 2020-04-30 | 56.88% | −9.47 pp |
| Q4 2020 | 2020-01-31 | 56.50% | −2.15 pp |
| Q3 2020 | 2019-10-31 | 61.12% | −3.87 pp |
| Q2 2020 | 2019-07-31 | 67.46% | +1.93 pp |
| Q1 2020 | 2019-04-30 | 66.34% | +2.89 pp |
| Q4 2019 | 2019-01-31 | 58.65% | +6.29 pp |
| Q3 2019 | 2018-10-31 | 64.99% | +5.60 pp |
| Q2 2019 | 2018-07-31 | 65.54% | +2.59 pp |
| Q1 2019 | 2018-04-30 | 63.45% | +2.57 pp |
| Q4 2018 | 2018-01-31 | 52.36% | +0.61 pp |
| Q3 2018 | 2017-10-31 | 59.39% | −0.32 pp |
| Q2 2018 | 2017-07-31 | 62.94% | −1.68 pp |
| Q1 2018 | 2017-04-30 | 60.88% | −2.01 pp |
| Q4 2017 | 2017-01-31 | 51.76% | +0.40 pp |
| Q3 2017 | 2016-10-31 | 59.71% | +1.87 pp |
| Q2 2017 | 2016-07-31 | 64.62% | +3.68 pp |
| Q1 2017 | 2016-04-30 | 62.89% | +2.91 pp |
| Q4 2016 | 2016-01-31 | 51.36% | +1.05 pp |
| Q3 2016 | 2015-10-31 | 57.85% | +1.90 pp |
| Q2 2016 | 2015-07-31 | 60.95% | +4.61 pp |
| Q1 2016 | 2015-04-30 | 59.99% | +3.35 pp |
| Q4 2015 | 2015-01-31 | 50.31% | −4.63 pp |
| Q3 2015 | 2014-10-31 | 55.95% | +0.26 pp |
| Q2 2015 | 2014-07-31 | 56.34% | — |
| Q1 2015 | 2014-04-30 | 56.64% | — |
| Q3 2014 | 2013-10-31 | 54.94% | — |
| Q2 2014 | 2013-07-31 | 55.69% | — |
Over the last five reported fiscal years, Healthequity's gross margin increased from 56.62% to 69.52%, a change of +12.90 percentage points. The latest reported quarter, Q1 2027, shows 72.27%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Healthequity filings at SEC.gov ↗